Pexastimogene devacirepvec
Pexastimogene devacirepvec Uses, Dosage, Side Effects, Food Interaction and all others data.
Pexastimogene devacirepvec is under investigation in clinical trial NCT00429312 (A Study of Recombinant Vaccinia Virus to Treat Malignant Melanoma).
| Trade Name | Pexastimogene devacirepvec |
| Generic | Pexastimogene devacirepvec |
| Pexastimogene devacirepvec Other Names | Pexastimogene devacirepvec |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Pexastimogene devacirepvec
